Page last updated: 2024-08-17

quinidine and cifenline

quinidine has been researched along with cifenline in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19906 (30.00)18.7374
1990's5 (25.00)18.2507
2000's5 (25.00)29.6817
2010's4 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Esterbrooks, DJ; Hansen, JM; Hilleman, DE; Mohiuddin, SM; Mooss, AN; Woodruff, MP1
Hasegawa, J; Hirokane, Y; Kotake, H; Mashiba, H; Nawada, T; Noguchi, N1
Somberg, J1
Flowers, NC; Maldonado, C; Palakurthy, PR; Sohi, G1
Barr, MJ; Saksena, S; Wasty, N1
Aogaichi, K; Butler, B; Keren, G; Miura, D; Somberg, J; Tepper, D1
Lüderitz, B; Manz, M1
Brembilla-Perrot, B; Gabriel, A; Lardoux, H; Levy, S; Marchand, X; Scheck, F; Touboul, P1
Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A1
Adamantidis, M; Cardinal, R; Delfaut, P; Dupuis, B; Kacet, S; Klug, D; Lacroix, D1
Allessie, MA; Dorland, R; Wijffels, MC1
Allessie, MA; Dorland, R; Mast, F; Wijffels, MC1
Kagayama, A; Mitani, Y; Niwa, T; Shiraga, T; Terakawa, M; Tokuma, Y1

Reviews

2 review(s) available for quinidine and cifenline

ArticleYear
Antiarrhythmic drug therapy. Recent advances and current status.
    Cardiology, 1985, Volume: 72, Issue:5-6

    Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil

1985
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
    European heart journal, 1993, Volume: 14 Suppl E

    Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil

1993

Trials

3 trial(s) available for quinidine and cifenline

ArticleYear
Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:4

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Female; Follow-Up Studies; Heart Ventricles; Humans; Imidazoles; Male; Middle Aged; Quinidine; Random Allocation

1989
Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    American heart journal, 1985, Volume: 110, Issue:6

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Imidazoles; Male; Middle Aged; Quinidine; Research Design

1985
[Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Annales de cardiologie et d'angeiologie, 1995, Volume: 44, Issue:9

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Quinidine; Recurrence

1995

Other Studies

15 other study(ies) available for quinidine and cifenline

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
    Cardiovascular research, 2011, Jul-01, Volume: 91, Issue:1

    Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection

2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

    Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Transient increase in the contractile force induced by antiarrhythmic drugs in guinea pig cardiac muscles.
    The American journal of cardiology, 1989, May-01, Volume: 63, Issue:15

    Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Guinea Pigs; Imidazoles; In Vitro Techniques; Myocardial Contraction; Quinidine

1989
Cibenzoline for high-frequency ventricular arrhythmias: a short-term comparison with quinidine and a long-term follow-up.
    Journal of clinical pharmacology, 1987, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Quinidine

1987
The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog.
    Journal of clinical pharmacology, 1984, Volume: 24, Issue:10

    Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electric Stimulation; Electrophysiology; Heart Rate; Imidazoles; Injections, Intravenous; Quinidine; Tachycardia

1984
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Archives des maladies du coeur et des vaisseaux, 1997, Volume: 90, Issue:7

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors

1997
Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
    Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:1

    Topics: Action Potentials; Animals; Anisotropy; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Female; Flecainide; Heart; Heart Conduction System; Imidazoles; In Vitro Techniques; Pericardium; Potassium Channel Blockers; Quinidine; Swine

1998
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Journal of cardiovascular electrophysiology, 1999, Volume: 10, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Electrocardiography; Flecainide; Follow-Up Studies; Goats; Heart Conduction System; Imidazoles; Injections, Intravenous; Quinidine; Secondary Prevention; Sotalol; Treatment Outcome

1999
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Circulation, 2000, Jul-11, Volume: 102, Issue:2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Goats; Heart Conduction System; Imidazoles; Quinidine; Sotalol

2000
Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:9

    Topics: Animals; Anti-Arrhythmia Agents; Aryl Hydrocarbon Hydroxylases; beta-Naphthoflavone; Cell Line; Chromatography, High Pressure Liquid; Clofibrate; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Female; Humans; Imidazoles; Ketoconazole; Kinetics; Male; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Phenobarbital; Quinidine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sex Factors; Stereoisomerism

2000